On May 23 (Monday) another meeting of the Transparency Council.
The agenda includes:
Preparation of positions on the legitimacy of changing medical technology in the field of:
• guaranteed services in the field of ICD-9 procedures: 84,502 - introduction of growth factors of autogenous origin and ICD-9: 84,503 - introduction of growth factors from stem cells with an indication of the scope of indications for use,
• PET/MRI health care services with the use of [18F] -FDG in oncological indications (for initial ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
